Related Experiment Video
Updated: Aug 14, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
[Ovarian and endometrial neoplasms and the use of hormone replacement therapy]
Abstract:
Our research work summarize our and foreign Experience in the field of hormone replacement therapy and its use in endometrial and ovarian cancers. We look at the effects of the treatment on coronary heart diseases, venous thromboembolism, breast cancer and colorectal cancer. Results and examinations from other centers and clinics were included in our study treating the endometrial and ovarian cancers and the hormonal replacement therapy. Our aim was to work out guidelines and rules on prescribing hormone replacement therapy in clinical practice especially in oncogynecological malignancies.
Related Concept Videos
Disorders of the Female Reproductive System
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
Oogenesis
Hormonal Control of the Ovarian Cycle
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Menopause
Ovarian Cycle
